Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for Fatigue in Multiple Sclerosis
NCT01149525Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jun 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing L-Carnitine with Placebo (2 arms). Primary endpoint: Modified Fatigue Impact Scale at 9 months. Started Jun 2010; status: completed.
02
Drugs
levocarnitine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01149525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149525.